• Luminal Gastroenterology
• 31 min
  1. Novel treatments for GI malignancies

  • Prof. Bert H. O'Neil
• 40 min
  2. The spectrum of GERD implications for assessment and management

  • Prof. Eamonn M. M. Quigley
• 54 min
  3. Oro-pharyngeal and esophageal motility and dysmotility

  • Dr. John E. Pandolfino
• 55 min
  4. Eosinophilic esophagitis and other non-reflux esophageal disorders

  • Prof. David Katzka
• 39 min
  5. Disorders of gastric function: gastroparesis and functional dyspepsia 1

  • Dr. Braden Kuo
• 17 min
  6. Disorders of gastric function: gastroparesis and functional dyspepsia 2

  • Dr. Braden Kuo
• 48 min
  7. Acid-peptic diseases of the stomach and duodenum including Helicobacter pylori and NSAIDs

  • Prof. Sheila Crowe
• 48 min
  8. Gastric cancer, gastritis and the role of H. pylori

  • Prof. Anthony Axon
• 48 min
  9. Celiac disease

  • Prof. Ciaran Kelly
• 43 min
  10. IBD for the non-gastroenterologist

  • Prof. Sunanda Kane
• 34 min
  11. The enteric microbiota in health and disease

  • Dr. Francisco Guarner
• 45 min
  12. Colorectal cancer and hereditary colon cancer syndromes

  • Prof. Carol A. Burke
• 39 min
  13. The spectrum of GI ischemia 1

  • Prof. Lawrence J. Brandt
• 31 min
  14. The spectrum of Gl ischemia 2

  • Prof. Lawrence J. Brandt
• 41 min
  15. Constipation and defecation disorders

  • Prof. Satish S. C. Rao
• 40 min
  16. Diverticular disease of the colon

  • Dr. Dale Vimalachandran
• 73 min
  17. Irritable bowel syndrome (IBS)

  • Prof. Eamonn M. M. Quigley
• 27 min
  18. Evidence-based management of non-variceal upper GI bleeding

  • Prof. Joseph J. Sung
• Hepatology
• 32 min
  19. Hepatitis B virus (HBV)

  • Prof. Marco Olivera-Martinez
• 26 min
  20. Hepatitis C - cure of infection

  • Prof. Mark Mailliard
• 46 min
  21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI

  • Prof. James H. Lewis
• 26 min
  22. Drug-induced liver injury: risk factors and drug development in DILI

  • Prof. James H. Lewis
• 39 min
  23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI

  • Prof. James H. Lewis
• 22 min
  24. Portal hypertension

  • Prof. John Reinus
• 55 min
  25. Portal hypertension: at the bedside

  • Dr. Clara Y. Tow
• 29 min
  26. The management of chronic liver disease, including transplantation 1

  • Prof. Timothy M. McCashland
• 21 min
  27. The management of chronic liver disease, including transplantation 2

  • Prof. Timothy M. McCashland
• 34 min
  28. Hereditary hemochromatosis: what have we learnt from population studies

  • Prof. John K. Olynyk
• 38 min
  29. Immune-mediated liver disease

  • Dr. Jenny Heathcote
• 51 min
  30. Alcoholic liver disease

  • Prof. Michael Lucey
• The Pancreas and Biliary Tree
• 46 min
  31. Acute pancreatitis

  • Prof. Davor Štimac
• 49 min
  32. Chronic pancreatitis

  • Prof. Christopher Forsmark
• 47 min
  33. Pancreatic cancer

  • Prof. Randall Brand
• 20 min
  34. The management of gallstones in relation to laparoscopic cholecystectomy and gallbladder dyskinesia

  • Prof. John Baillie
• Archived Lectures *These may not cover the latest advances in the field
• 52 min
  35. The management of other aspects of chronic liver disease, including transplantation

  • Prof. Timothy M. McCashland
• 38 min
  36. Chronic viral hepatitis B and C

  • Prof. Mark Mailliard
• 41 min
  37. Pancreatic cancer

  • Prof. Randall Brand
• 72 min
  38. Acute viral hepatitis

  • Prof. Geoffrey Dusheiko
• 33 min
  39. Diverticular disease

  • Dr. Charles Knowles
• 57 min
  40. The spectrum of gastrointestinal ischemia: 2010

  • Prof. Lawrence J. Brandt
• 51 min
  41. Acute pancreatitis

  • Prof. Davor Štimac

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Criteria for diagnosis of AILD
3. Autoimmune Hepatitis (AIH)
4. Spectrum of AIH in 2008
5. Differential diagnosis: AIH
6. Drugs inducing an AIH-like syndrome
7. Diagnosis of Wilson disease Leipzig score
8. Steps in management of AIH
9. Simplified criteria for diagnosis of AIH
10. When to question initiation of AIH treatment
11. Screening before IST for AIH
12. Indication for AIH treatment
13. AIH: response to immunosuppressive therapy
14. Treatment regiments for adults
15. Standard therapy : AIH
16. AIH: preventative measures while on treatment
17. Monitoring required during IST for AIH
18. AIH: remission following therapy
19. Remission following IST withdrawal
20. AIH: maintenance therapy with Azathioprine
21. Treatment failure
22. Primary & secondary sclerosing cholangitis
23. Potential pathogenesis: sclerosing cholangitis
24. Magnetic Resonance Cholangiography
25. Role of ERCP in PSC
26. PSC: Presenting Features
27. Ulcerative colitis: link to PSC
28. PSC with Inflammatory Bowel Disease (IBD)
29. Survival IBD vs. IBD+PSC
30. Causes of death in 45 patients: PSC
31. RCT: Ursodeoxycholic acid - PSC
32. Why medical therapy fails in PSC?
33. Recurrent AILD after OLT
34. Primary Biliary Cirrhosis (PBC)
35. PBC- physical presentation
36. Typical presentation of PBC in 2009
37. Meta analysis: RCT in UDCA for PBC
38. Liver transplant
39. Longterm survival in early PBC
40. Survival in PBC +/- Biochemical response
41. Survival according to PHG score
42. PBS: natural history
43. Treatment response and histological change
44. Complications of PBC
45. What is the drive and the trigger?
46. PBC cases in first degree relatives
47. PBC: genome wide analysis
48. The genetic web of autoimmunity
49. Acknowledgments

Topics Covered

• Diagnosis of Autoimmune Liver Disease (AILD)
• Diagnosis of Autoimmune Hepatitis (AIH)
• Steps in management of AIH
• AIH treatment
• Response to immunosuppressive therapy in AIH
• Monitoring during IST for AIH
• Remission following therapy in AIH
• Presenting features of primary & secondary Sclerosing Cholangitis (PSC)
• Ulcerative colitis: link to PSC
• PSC with Inflammatory Bowel Disease (IBD)
• Causes of death in PSC
• PSC treatment
• Medical therapy failure in PSC
• Typical presentation of Primary Biliary Cirrhosis (PBC)
• Liver transplant in PBC vs. PSC
• Survival in PBC
• Treatment response and histological change in PBC
• Complications of PBC

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Clinical Practice
• Immunology

Therapeutic Areas:

• Gastroenterology & Nephrology
• Immunology & Inflammation

Talk Citation

Publication History

• Published on January 30, 2011

Financial Disclosures

• Dr. Jenny Heathcote has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.